Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Algeta, Aspiring For Solo Success, Draws Bayer Bid After Xofigo Launch

Executive Summary

The Norwegian biotech is keen to show it is not a one-trick pony, but its future might lie in the embrace of its big pharma partner Bayer.

You may also be interested in...



CardiNor Leads The Charge As Norway Gets Behind Life Sciences

Norwegian start-up CardiNor is developing a new cardiovascular biomarker, and is hopeful of attracting cash in a country where investor traditions are undergoing some changes. The financial pressures caused by falling oil prices have brought renewed attention to life science companies.

Advanced Accelerator Preps Lutetium-Tipped Warhead For NETs Filings

France’s Advanced Accelerator Applications is making plans to extend its business to the US after its lead radiotherapeutic, a lutetium labelled somatostatin analog, met its primary endpoint in a Phase III study.

Abingworth Attracts $375M For Its New Bioventures Fund

The committed capital is nearly half what the 40-year-old firm raised from its previous vehicle and its sidecar in 2007–2008, but it's a huge sum compared with what most life science VCs can drum up these days.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

PS055769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel